Appointment of departing NICE Health Technology Evaluation Centre Director as ABPI Chief Scientific Officer

Professor Carole Longson MBE is to depart as Director of NICE’s Health Technology Evaluation Centre to take up the role of Chief Scientific Officer at the Association of the British Pharmaceutical Industry (ABPI). Professor Longson will be responsible for leading the Research, Medical and Innovation function at the ABPI, with a remit to shape and develop UK pharmaceutical science policy and to ensure that the UK remains at the forefront of innovation in medicines research, development and manufacturing. She will move on to her new role on 12 April after 17 years at NICE, but will step down from her current responsibilities with immediate effect, with deputy director Mirella Marlow acting as Centre Director from 24 January.

Sir Andrew Dillon, chief executive of NICE said: “I am very sorry to lose her from NICE but I wish her well in her new role, where she will have the opportunity to influence scientific endeavour in other parts of the life sciences system.”

Mike Thompson, Chief Executive of the ABPI, said: “The appointment of Carole Longson to this new post signals our commitment to strengthening our focus on science, research and discovery in the UK and the role our members play in developing new innovative medicines and vaccines. Her scientific research and academic experience, along with her integrity, perspective and vision can really help us continue to transform the pharmaceutical industry in the UK.”

Tagged with

Published 24. January 2018 in News UK